Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Secondary neutron doses in proton therapy treatments of ocular melanoma and craniopharyngioma.
Authors: Farah J,  Sayah R,  Martinetti F,  Donadille L,  Lacoste V,  Hérault J,  Delacroix S,  Nauraye C,  Vabre I,  Lee C,  Bolch WE,  Clairand I
Journal: Radiat Prot Dosimetry
Date: 2014 Oct
Branches: REB
PubMed ID: 24222710
PMC ID: not available
Abstract: Monte Carlo simulations were used to assess secondary neutron doses received by patients treated with proton therapy for ocular melanoma and craniopharyngioma. MCNPX calculations of out-of-field doses were done for ∼20 different organs considering realistic treatment plans and using computational phantoms representative of an adult male individual. Simulations showed higher secondary neutron doses for intracranial treatments, ∼14 mGy to the salivary glands, when compared with ocular treatments, ∼0.6 mGy to the non-treated eye. This secondary dose increase is mainly due to the higher proton beam energy (178 vs. 75 MeV) as well as to the impact of the different beam parameters (modulation, collimation, field size etc.). Moreover, when compared with published data, the assessed secondary neutron doses showed similar trends, but sometimes with sensitive differences. This confirms secondary neutrons to be directly dependent on beam energy, modulation technique, treatment configuration and methodology.